These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16272782)

  • 1. Inappropriate discharges of intravenous implantable cardioverter defibrillators owing to lead failure.
    Washizuka T; Chinushi M; Kazama R; Hirono T; Watanabe H; Komura S; Sugiura H; Tanabe Y; Furushima H; Fujita S; Okura Y; Aizawa Y
    Int Heart J; 2005 Sep; 46(5):909-13. PubMed ID: 16272782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographically documented unnecessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators.
    Grimm W; Flores BF; Marchlinski FE
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 1):1667-73. PubMed ID: 1279533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Gillberg JM; Wood MA; Vijayaraman P; Shepard RK; Ellenbogen KA
    Heart Rhythm; 2006 Feb; 3(2):155-62. PubMed ID: 16443529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator.
    Zhu Y; Gu X; Xu C
    BMC Cardiovasc Disord; 2017 Oct; 17(1):265. PubMed ID: 29037154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvenous defibrillation leads: high incidence of failure during long-term follow-up.
    Dorwarth U; Frey B; Dugas M; Matis T; Fiek M; Schmoeckel M; Remp T; Durchlaub I; Gerth A; Steinbeck G; Hoffmann E
    J Cardiovasc Electrophysiol; 2003 Jan; 14(1):38-43. PubMed ID: 12625608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An algorithm to predict implantable cardioverter-defibrillator lead failure.
    Gunderson BD; Patel AS; Bounds CA; Shepard RK; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 2004 Nov; 44(9):1898-902. PubMed ID: 15519026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvenous cardioverter defibrillator lead malfunction due to terminal connector damage in pectoral implants.
    Mera F; DeLurgio DB; Langberg JJ; Moss EA; Léon AR
    Pacing Clin Electrophysiol; 1999 Dec; 22(12):1797-801. PubMed ID: 10642134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High incidence of isolator fractures in transvenous implantation of cardioverter defibrillators].
    Mewis C; Kühlkamp V; Dörnberger V; Mermi J; Seipel L
    Z Kardiol; 1997 Feb; 86(2):85-94. PubMed ID: 9173702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ventricular fibrillations with different characteristics in the local electrocardiogram: large and small amplitude of activation, and its implication for implantable cardioverter defibrillator treatment.
    Chinushi M; Washizuka T; Kasai H; Ohhira K; Satoh M; Aizawa Y
    Jpn Circ J; 1999 Dec; 63(12):1007-10. PubMed ID: 10614851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Problems and complications after implantation of automatic defibrillators].
    Trappe HJ; Klein H; Fieguth HG; Wenzlaff P; Lichtlen PR
    Med Klin (Munich); 1993 Nov; 88(11):619-28. PubMed ID: 8295602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Klein RC; Raitt MH; Wilkoff BL; Beckman KJ; Coromilas J; Wyse DG; Friedman PL; Martins JB; Epstein AE; Hallstrom AP; Ledingham RB; Belco KM; Greene HL;
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9):940-8. PubMed ID: 12950538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
    Osswald S; Candinas R; Fuhrer J
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.